Christoph  Baldegger, primary  insider and  member of  the board of directors in
Hofseth  BioCare ASA  ("HBC") has  today purchased  100,000 shares in  HBC at an
average  price  of  NOK  2.72 per  share.  As  a  result of the transaction, Mr.
Baldegger  holds 800,000 shares  in HBC,  equal to  approximately 0.20 %  of the
outstanding shares.

Please see the attached notification form for further information.

Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

This  information is subject to the  disclosure requirements in the Market Abuse
Regulation  EU 596/2014 article 19 number 3 and the Norwegian Securities Trading
Act section 5-12.